维普中文期刊产品整合服务
117篇 您的检索式:作者名="Paul JM"
    题名 作者 年代 出处 被引量
1Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno-or squamous cell carcinoma显示文摘AIM:To determine whether-1195 A→G and/or-765 G→C polymorphisms in Cyclooxygenase-2(COX-2 ) may have a risk modifying effect on the development of esophageal carcinoma in a Dutch Caucasian population.METHODS:Two study groups were recruited, 252 patients with esophageal carcinoma and 240 healthy controls, matched for race, age, gender and recruiting area.DNA was isolated from whole blood and used for genotyping.PCR products were digested with restriction enzymes and products were analyzed by agarose gel electrophoresis.Odds ratios(OR) and 95% confldence intervals(CI) were estimated.RESULTS:The distribution of the-1195 A→G polymorphism was signif icantly different in esophageal cancer patients compared to controls.The-1195 GG genotype resulted in a higher risk of developing esophageal adenocarcinoma(OR = 3.85, 95% CI:1.45-10.3) compared with the-1195 AA genotype as a reference.The-765 G→C genotype distribution was not different between the two groups.The GG/ GG haplotype was present more often in esophageal adenocarcinoma patients than in controls(OR = 3.45, 95% CI:1.24-9.58;with AG/AG as a reference).The same trends were observed in patients with squamous cell carcinomas, however, the results did not reach statistical signif icance.CONCLUSION:Presence of the COX-2-1195 GG genotype and of the GG/GG haplotype may result in a higher risk of developing esophageal carcinoma.Jón O Kristinsson Paul van Westerveld Rene HM te Morsche Hennie MJ Roelofs T Wobbes Ben JM Witteman Adriaan CITL Tan Martijn GH van Oijen Jan BMJ Jansen Wilbert HM Peters 2009World Journal of Gastroenterology2009,15,28:11
2Trends in treatment and overall survival among patients with proximal esophageal cancer显示文摘BACKGROUND The management of proximal esophageal cancer differs from that of tumors located in the mid and lower part of the esophagus due to the close vicinity of vital structures.Non-surgical treatment options like radiotherapy and definitive chemoradiation(CRT)have been implemented.The trends in(non-)surgical treatment and its impact on overall survival(OS)in patients with proximal esophageal cancer are unclear,related to its rare disease status.To optimize treatment strategies and counseling of patients with proximal esophageal cancer,it is therefore essential to gain more insight through real-life studies.AIM To establish trends in treatment and OS in patients with proximal esophageal cancer.METHODS In this population-based study,patients with proximal esophageal cancer diagnosed between 1989 and 2014 were identified in the Netherlands Cancer Registry.The proximal esophagus consists of the cervical esophagus and the upper thoracic section,extending to 24 cm from the incisors.Trends in radiotherapy,chemotherapy,and surgery,and OS were assessed.Analyses were stratified by presence of distant metastasis.Multivariable Cox proportional hazards regression analyses was performed to assess the effect of period of diagnosis on OS,adjusted for patient,tumor,and treatment characteristics.RESULTS In total,2783 patients were included.Over the study period,the use of radiotherapy,resection,and CRT in non-metastatic disease changed from 53%,23%,and 1%in 1989-1994 to 21%,9%,and 49%in 2010-2014,respectively.In metastatic disease,the use of chemotherapy and radiotherapy increased over time.Median OS of the total population increased from 7.3 mo[95%confidence interval(CI):6.4-8.1]in 1989-1994 to 9.5 mo(95%CI:8.1-10.8)in 2010-2014(logrank P<0.001).In non-metastatic disease,5-year OS rates improved from 5%(95%CI:3%-7%)in 1989-1994 to 13%(95%CI:9%-17%)in 2010-2014(logrank P<0.001).Multivariable regression analysis demonstrated a significant treatment effect over time on survival.In metastatic disease,median OS was 3.8 mo(95%CI:2.5-5.1)in 1989-1994,and 5.1 mo(95%CI:4.3-5.9)in 2010-2014(logrank P=0.26).CONCLUSION OS significantly improved in non-metastatic proximal esophageal cancer,likely to be associated with an increased use of CRT.Patterns in metastatic disease did not change significantly over time.Judith de Vos-Geelen Sandra ME Geurts Liselot BJ Valkenburg-van Iersel Evelien JM de Jong Vivianne CG Tjan-Heijnen Margreet van Putten Valery EPP Lemmens Heike I Grabsch Nadia Haj Mohammad Frank JP Hoebers Chantal V Hoge Paul M Jeene Hanneke WM van Laarhoven Tom Rozema Marije Slingerland Grard AP Nieuwenhuijzen 2019World Journal of Gastroenterology2019,25,47:2
3Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials显示文摘Naveed Sattar David Preiss Heather M Murray Paul Welsh Brendan M Buckley Anton JM de Craen Sreenivasa Rao Kondapally Seshasai John J McMurray Dilys J Freeman J Wouter Jukema Peter W Macfarlane Chris J Packard David J Stott Rudi G Westendorp James Shepherd 2010The Lancet2010,,9716:2
4Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials显示文摘Naveed Sattar David Preiss Heather M Murray Paul Welsh Brendan M Buckley Anton JM de Craen Sreenivasa Rao Kondapally Seshasai John J McMurray Dilys J Freeman J Wouter Jukema Peter W Macfarlane Chris J Packard David J Stott Rudi G Westendorp James Shepherd 2010The Lancet2010,,9716:2
5Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease 显示文摘Powell TM Paul JD Hill JM 2005Arterioscler Thromb Vasc Biol2005,25,2:1
6Fatigue and its impact on patients with myasthenia gravis显示文摘Paul RH Cohen RA Gilehrist JM 2000Muscle Nerves2000,23,:1
7Largely typical patterns of resting-state functional connectivity in high-functioning adults with autism显示文摘Yyszka JM Kennedy DP Paul LK 2014Cereb Cortex2014,24,7:1
8Cognitive dysfunction in individuals with myasthenia gravis显示文摘Paul RH Cohen RA Gilchrist JM 2000J Neurol Sci2000,179,12:1
9Ratings of subjective mental fatigue relate to cognitive performance in patients with myasthenia gravis显示文摘Paul RH Cohen RA Gilchrist JM 2002J Clin Neurosci2002,9,3:1
10Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease显示文摘Powell TM Paul JD Hill JM 2005Arterioscler Thromb Vasc Biol2005,25,2:1
11Regulation of intestinal blood flow 显示文摘Paul JM Mark AW Neal RG 2000J Surg Res2000,93,1:1
12Safety of topical calcineurin inhibitors for the treatment of atopie dermatitis 显示文摘Paul JM Jenny JM 2007Pharmacother2007,27,7:1
13Treatment of complete obstruction of the nasolacrimal system by temporary placement of nasolacrimal polyurethane stents:preliminary results显示文摘 Pinto I Vicente JM 2003Clin Radiol2003,58,:1
14Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety显示文摘Gatt JM Nemeroff CB Dobson-Stone C Paul RH Bryant RA Schofield PR 2009Mol Psychiatry2009,14,7:1
15Granulocyte colony - stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease 显示文摘Powell TM Paul JD Hill JM 2005Arterioseler Thromb Vasc Biol2005,25,2:1
16Close physical linkage of human troponin genes organization, sequence, and expression of the locus encoding cardiac troponin I and slow skeletal troponin T显示文摘Anthony JM Paul JB 1999Genomics1999,57,1:1
17Development of novel treatments for hepatitis C显示文摘Daniel P Webster Paul Klenerman Jane Collier Katie JM Jeffery 2009The Lancet Infectious Diseases2009,,2:1
18Cogniti,te dysfunction in individuals with myasthenia gravis 显示文摘Paul RH Cohen RA Gilchrist JM 2000J Neurol Sci2000,179,:1
19Risk factors for falls among older a- dults :a review of the literature显示文摘Ambrose AF Paul G Hausdorff JM 2013Maturitas2013,75,1:1
20Internal fixation of unstable pelvic ring injuries显示文摘Matta JM Paul Tornetta 1996Clin Orthop1996,329,8:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费